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ABSTRACT 
Rationale 
The NEWMEDS initiative (Novel Methods leading to New Medications in Depression 
and Schizophrenia, http://www.newmeds-europe.com) is a large industrial-academic 
collaborative project aimed at developing new methods for drug discovery for 
schizophrenia. As part of this project, Work package 2 (WP02) has developed and 
validated a comprehensive battery of novel touchscreen tasks for rats and mice for 
assessing cognitive domains relevant to schizophrenia.  
 
Objectives 
This article provides a review of the touchscreen battery of tasks for rats and mice for 
assessing cognitive domains relevant to schizophrenia and highlights validation data 
presented in several primary articles in this issue and elsewhere. 
 
Methods  
The battery consists of the 5-choice serial reaction time task and a novel rodent 
continuous performance task for measuring attention, a 3-stimulus visual reversal and 
the serial visual reversal task for measuring cognitive flexibility, novel nonmatching-to-
sample based tasks for measuring spatial working memory and paired-associates 
learning for measuring long term memory. 
 
Results 
The rodent (i.e. both rats and mice) touchscreen operant chamber and battery has 
high translational value across species due to its emphasis on construct as well as 
face validity. In addition, it offers cognitive profiling of models of diseases with 
  
cognitive symptoms (not limited to schizophrenia) through a battery approach, 
whereby multiple cognitive constructs can be measured using the same apparatus, 
enabling comparisons of performance across tasks. 
 
Conclusion 
This battery of tests constitutes an extensive tool package for both model 
characterisation and preclinical drug discovery. 
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INTRODUCTION 
 
The need for treatment of cognitive dysfunction in schizophrenia 
Schizophrenia is a chronic brain disorder caused by a complex and largely unknown 
polygenetic and environmental interplay producing dysfunctions in brain circuitry within 
and between prefrontal cortical and subcortical structures (Harrison, 1999). These 
dysfunctions are behaviourally expressed by disturbances of perception, emotion and 
thinking; often referred to as positive, negative and cognitive symptoms, respectively.  
While available neuroleptics can show good efficacy against the positive 
symptoms as well as moderate efficacy against the negative symptoms, they have 
frequently been found to have no effects or even detrimental effects on cognition 
(Weiss et al, 2002). Yet, the degree of cognitive decline correlates better with recovery 
prognoses than positive or negative symptoms, and deficits in executive function, 
working memory and verbal memory are stable and detectable in the prodromal period 
(O’Carroll, 2000; Barnett et al, 2005; Simon et al, 2007). The inability of available 
neuroleptics to ameliorate these deficits severely limits treatment progression, and is 
believed to be the cause of the often poor long-term health outcome associated with 
diagnosis despite existing medication (Green, 1996, 2006; Holthausen et al, 2007; 
Keefe et al, 2007). However, attempts at tackling this unmet patient need has not 
resulted in any major advancement – indeed, chlorpromazine (approved in 1954), 
haloperidol (approved in 1962) and clozapine (approved in 1972) remain the standard 
treatments.  
 
Drug discovery: limitations of prevalent approaches  
Although preclinical science and increased research and development expenditure 
has provided a wealth of possible drug targets for cognitive improvement in 
  
schizophrenia, this increase in knowledge has so far brought no relief to the patient. A 
number of challenges have been outlined for realising treatment options from basic 
preclinical research. Some have emphasised the urgent need for reliable, dose-
sensitive preclinical behavioural assays with high construct validity (Moore et al, 2013) 
and replication of behavioural findings following genetic (Crabbe et al, 1999) or 
pharmacological manipulations in experimental animals through private-public pre-
competitive knowledge exchange (Insel et al, 2013). Prevalent preclinical assays are 
often non-automated, hand-run tasks with limited application for high-throughput drug 
discovery. The current rate of translation of preclinical findings into knowledge of the 
aetiology of schizophrenia and novel therapeutics also suggests lack of validity. While 
the solution to increasing the success rate within mental health drug discovery is 
unlikely to be unitary, improving the translational value of preclinical assays is a 
necessary milestone for making informed decisions about target selection and 
compound efficacy.  
 
The NEWMEDS approach 
To address these challenges, the NEWMEDS consortium represents a pre-
competitive industry-academia collaboration consisting of 9 major biopharmaceutical 
and academic partners with the aim of improving of treatment options for cognitive 
deficits in schizophrenia and depression. Within this consortium, Work Package 2 is 
focused on animal models of cognitive dysfunction that relate to clinical endpoints. An 
objective of this work package has been to develop a novel battery of validated 
neuropsychological tests of cognition that provide preclinical measures in rodents that 
parallel those affected in patients with schizophrenia (see Fig. 1 for an overview of the 
structure of the consortium). This battery consists of the 5-choice serial reaction time 
task and a novel rodent continuous performance task to measure attention, a 2 or 3-
  
stimulus visual reversal task and the serial visual reversal task to measure cognitive 
flexibility, novel nonmatching-to-sample-based tasks to measure spatial working 
memory and paired-associates learning to measure long term memory.  
 Validation of the current battery was aimed at establishing neurocognitive 
(construct) validity, whereby task performance in the rodent depends on the expected 
psychological processes and their associated neural systems or mechanisms. This 
can be demonstrated by varying parametrically those task parameters that load on the 
specific construct of interest, e.g. 'working memory' and showing comparable effects in 
experimental animals and humans. Additional validation is provided by demonstrations 
that task performance depends on homologous neural or neurochemical structures or 
systems (e.g. 'fronto-striatal' or hippocampal or dopaminergic), as has been shown in 
humans. Finally, validation would be also achieved by demonstrating back-
translational effects e.g. of drug treatments from the clinic to analogous actions in 
animal models using comparable tasks. 
 Construct validity in this sense was established, for example, through 
excitotoxic lesioning or microinfusions of pharmacological agents at specific 
neuroanatomical regions critical for performance on human task equivalents. 
Furthermore, the test battery has been used to evaluate experimental rodent models 
(for example, by manipulation of genetic, neurodevelopmental or pharmacological 
factors) of schizophrenia-like phenotypes, and to assess the effect of novel 
compounds provided by biopharmaceutical partners. It is important to note that, 
regardless of which perturbation is used to generate the neuropathology and 
pathophysiology of the disorder (‘the ‘disease model’), the utility and predictive validity 
of animal models of neuropsychiatric disorders will depend critically on the behavioural 
test measures used. However, a lack of cognitive profile in an animal model relevant 
to the human condition cannot necessarily be interpreted as a failing of the cognitive 
  
test, as the disease process may not be adequately captured in that particular model. 
Indeed, uncertainty with regard to the validity of current ‘disease; models of 
schizophrenia is pervasive. In light of the circular difficulty of using tasks to evaluate 
models of disease/disorders, whilst using models of disease/disorders to evaluate 
tasks, establishing predicted sensitivity to manipulations of specific neural circuit 
mechanisms becomes increasingly critical. Ultimately, the replication of findings from 
clinical trials using patients with schizophrenia in pre-clinical work provides the most 
robust validation (Keeler and Robbins, 2011). Whilst this type of back-translation is not 
currently established for all of the novel tasks presented, it would be an important 
direction for future work.   
Cognitive domains requiring alleviation in schizophrenia and robust analogous 
pre-clinical measures have previously been identified by two initiatives for clinical and 
preclinical work, namely the Measurement and Treatment Research to Improve 
Cognition in Schizophrenia (MATRICS) and Cognitive Neuroscience Treatment 
Research to Improve Cognition in Schizophrenia (CNTRICS; see Table 1). Of these, 
CNTRICS has adopted a focus on the translational value of the tasks selected when 
possible, but several tasks still lack a clear rodent analogue. These consortiums have 
formed a solid basis for construct identification and task selection that has informed 
the work presented in this review.  
The CNTRICS and MATRICS domains are necessarily broad constructs, and 
are made up of a number of cognitive processes that can be defined independently. 
These “sub”-constructs interact and overlap, as is true for the identified constructs 
themselves (for example, perception contributes to all sub-domains to some extent; 
attention contributes to memory paradigms etc). The touchscreen battery of task in the 
present review can therefore be applied to a number of cognitive domains, as 
highlighted in Table 2. However, specific tasks are emphasised for their ability to 
  
manipulate variables particularly relevant to certain constructs. For example, whilst 
reversal learning is listed as involving visual learning, this is complete after the initial 
acquisition of a visual discrimination, and is not required for performance in the 
reversal phase, where cognitive flexibility is central. Therefore, the task is emphasised 
here in the context of its ability to assess cognitive flexibility, and is in terms of 
perception not designed to offer more than a basic measure of visual ability.  
 
The touchscreen operant chamber battery of tasks for assessing cognition in rats and 
mice  
The current review presents a series of touchscreen cognitive tasks that have been 
selected as a suggested battery for schizophrenia-oriented preclinical work in the 
rodent. For several cognitive constructs, a number of tasks have been developed that 
vary in task design and potential neurocognitive and neuropharmacological sensitivity. 
As with all validation work, the understanding of how to best utilise these newly 
developed tasks will further develop with use. 
 The use of touchscreen operant chambers is in our opinion a valuable step 
towards achieving high construct validity, as making the testing environment, stimuli 
and lack of aversive feedback as similar as possible in rodent behavioural testing to 
patient testing reduces the likelihood of polluting outcome measures with confounding 
variables. The development of the touchscreen approach for rodents was inspired in 
part by the established Cambridge Neuropsychological Test Automated Battery 
(CANTAB; Sahakian and Owen, 1992; Barnett et al, 2010), designed to assess 
specific mental functions to enable a profile of performance indicative of a particular 
patient group. CANTAB is based on cross-species neuropsychological work and 
emphasises the importance of dissecting cognitive function across tasks. For example, 
deficits in spatial planning may be related to issues in the encoding and maintenance 
  
of relevant information, the successful manipulation of that information, or both 
(Sahakian and Owen, 1992). Through decades of work with CANTAB, a rich 
understanding of the neural underpinnings of each task has been established (Barnett 
et al, 2010), and the battery has repeatedly identified deficits in long and short term 
memory, attention and executive function in patients with schizophrenia (Levaux et al, 
2007; Barnett et al, 2010). Through use of non-verbal stimuli, the CANTAB battery 
allows for simple back-translation to preclinical work, enabling the development of a 
parallel touchscreen battery for animals including rodents.   
The touchscreen operant chamber offers an ideal opportunity to develop 
reliable preclinical assays for a wide range of cognitive functions through easily 
implementable, automated, non-aversive, standardised, flexible and valid behavioural 
assays (Bussey et al, 2012). A major advantage of touchscreen-based preclinical 
testing is the translational value in terms of both construct and face validity, as well as 
the ability to assess multiple cognitive constructs using the same apparatus. This 
allows for comparisons across cognitive tasks (to decompose cognitive processes), 
and mirrors the CANTAB battery approach in enabling behavioural phenotyping 
relevant to specific neuropsychiatric or neurodegenerative disease (for further 
discussions on the translational validity of this approach, see Bussey et al, 2008, 
2012; Horner et al, 2013; Oomen et al, 2013; Mar et al, 2013). The touchscreen 
testing environment therefore offers a superior setting for high-throughput behavioural 
phenotyping, pharmacological characterisation, cross-site replication studies and drug-
discovery. Many tasks are optimised for use with repeated pharmacological 
manipulations and all have near-identical clinical analogues for swift back-translation 
(Bussey et al, 2001, 2008, 2012; Keeler and Robbins, 2011; Mar et al, 2013; Horner et 
al, 2013; Oomen et al, 2013; Nithianantharajah et al, 2013). We hope that this 
  
approach can help shape the agenda for future studies and advance the field of 
behavioural neuroscience for targeting patient need. 
 
Continuous Performance Test (rCPT) 
Attentional dysfunction is at the core of the neurocognitive deficits of schizophrenia, as 
it is present throughout periods of both psychosis and remission (Wohlberg and 
Kornetsky, 1973; Asarnow and MacCrimmon, 1978; Nuechterlein et al, 1992). 
Attention is not a unitary construct, but is a composite term describing a defined set of 
interacting processes encompassing components of selection, vigilance and control 
(Parasuraman, 1992). Selection refers to processing selectively within a limited-
capacity system, and is sensitive to distracting stimuli. Vigilance (or sustained 
attention) refers to the maintenance of goal directed processing over time. 
Interestingly, task manipulations that reduce accuracy in selection increases vigilance 
(Bahri and Parasuraman, 1989), whilst increases in accuracy are associated with 
reduced vigilance (See et al, 1995). Vigilance and selection may therefore be 
competing and dissociable systems (Parasuraman, 1992). Attentional control refers to 
a wider concept of coordinating selection, vigilance and other concurrent cognitive 
processes, and as such shares features of executive function and working memory.  
 In light of the range of attentional constructs available for selection CNTRICS 
narrowed their definition to focus on tasks measuring attentional control in preclinical 
research, as patients with schizophrenia are impaired in this domain as compared to 
implementation of input selection (Luck and Gold, 2008; Nuechterlein et al, 2009). 
CNTRICS recommend the 5-choice Serial Reaction Time Task (5CSRTT; reviewed in 
Robbins, 2002), the 5-choice Continuous Performance Task (5CSRTT-CPT) and the 
Distractor Condition Sustained Attention Task (dSAT, McGaughy and Sarter, 1995; 
Lustig et al, 2013). We have focused on two similar tasks for development in the 
  
touchscreen, namely the CPT (Rosvold et al, 1956), and the well established 5CSRTT 
(Robbins, 2002). These tasks represent measures of sustained visual attention and 
divided spatial attention respectively, offering a comprehensive range of attentional 
measures when utilised as part of a battery.  
 Tests of attentional control should measure the ability to use internal 
representations to guide responding (Nuechterlein et al, 2009). CNTRICS defines two 
task essential task elements to address this; a baseline task (e.g. detection of a signal 
in the context of non-signals, guided mainly by “bottom-up” processing) and an 
addition to the baseline task that requires further cognitive recruitment to maintain 
performance (e.g., a flanker distractor, guided mainly by “top-down” processing). The 
CPT task fulfils these criteria for measuring attentional control. 
 The touchscreen rodent CPT (Mar et al, unpublished; Mar et al, 2012 poster; 
Mar et al, 2013 poster; Lei et al, 2014 poster) provides a translational measure of 
selective and sustained visual attention in the rodent. The task is designed to be highly 
analogous to the human CPT, versions of which have proven sensitive to detect 
impairments in patients with schizophrenia independent of clinical state (Asarnow and 
MaCrimmon, 1978) and in non-affected relatives (Grunebaum et al, 1974; 
Rutschmann et al, 1977; Erlenmeyer-Kimling and Comblatt 1992; Nuechterlein 1983; 
Mirsky et al, 1992; Franke et al, 1994; Laurent et al, 1999). The task has shown 
predictive power for disorder development (Cornblatt and Malhotra, 2001), with 
attentional impairments preceding clinical signs and symptoms of the illness (Cornblatt 
et al, 1997). 
 In the simplest human version of CPT, the subject must detect a target (e.g. the 
letter X) amongst non-targets (e.g. the letter Y) presented sequentially in one location 
on the screen. The rodent task utilises patterned stimuli rather than letters (e.g. 
vertical and horizontal stripes), but is otherwise identical in that animals must detect 
  
and respond directly to the target stimulus and withhold responding from non-target 
stimuli presented sequentially in a central location on the screen (see Fig 2). This 
allows rodent task performances to be analysed using signal detection theory, a 
measure of target detection in the context of noise analogous to human CPT 
measures. The use of both non-targets and the possibility of touching a blank screen 
during the inter-trial-interval (ITI) allows for measures of inhibitory control. A major 
advantage of the rCPT is the ability to include flanker distractors, in which congruent 
or incongruent stimuli are presented either side of the target area during stimulus 
presentations. Furthermore, the stimulus duration, probability of a target presentation, 
ITI, contrast of visual stimuli and the number of non-targets used can all be varied to 
create a wide and flexible tool set for probing attentional and perceptual functioning.  
 A number of studies have been conducted to validate the rCPT in terms of its 
sensitivity to detect performance alterations following brain lesions, within various rat 
and mouse models proposed to relate to schizophrenia, as well as to detect cognitive 
enhancements following treatment with nootropic compounds. Both rats and mice 
show impaired attentional performance following fibre-sparing, neurotoxic lesions of 
the medial prefrontal cortex (mPFC) observed as a reduction in d’ (i.e. sensitivity of 
targets to non-target stimuli), mirroring early human CPT data on patients with frontal 
lobe damage (Mar et al, unpublished). A comparison of commonly used mouse strains 
trained on the rCPT illustrates typical acquisition and performance levels for the 
mouse, and demonstrates sensitivity of the task to enhancements in performance 
following systemic administration of Donepezil (Kim et al, this issue). In NR1 knock-out 
mice of GABAergic interneurons (Belforte et al, 2010), the task is sensitive to 
impairments whereas the same mouse model is unaffected on the 5CSRTT (Hvoslef-
Eide et al, 2013 poster), supporting the interpretation that these two attentional 
paradigms assess different aspects of attention. Moreover, using three rat models 
  
proposed to model aspects of schizophrenia, a differential pattern of effects was 
observed between the offspring of dams injected with methylazoxymethanol acetate 
on embryonic day 17 (MAM-E17), rats that had been neonatally-treated with 
phencyclidine (neo-PCP) and animals subchronically administered PCP in adulthood 
(sub-PCP), relative to their respective controls (Mar et al, 2013 poster; Mar et al, 
unpublished). MAM-E17 rats showed marked elevations in false alarm rate and “blank” 
touch responses relative to sham controls, suggestive of deficits in inhibitory control. 
These MAM-E17 deficits have been demonstrated to be differentially modulated and in 
certain cases, selectively improved, following acute treatment with a variety of 
cognitive enhancers targeting monoaminergic, cholinergic glutamatergic or GABAergic 
systems (Mar et al, unpublished). In contrast to MAM-E17 rats, sub-PCP rats were 
largely unimpaired (Mar et al, 2013 poster) and neo-PCP rats actually showed 
improved target hit rates relative to their respective control animals (Mar et al, 
unpublished). However, both PCP-treated groups were differentially affected from their 
respective controls when the task stimuli were reduced in contrast which may suggest 
perceptual deficits similar to those observed in schizophrenic patients (Calderone et 
al, 2013).  
    
The touchscreen 5-Choice Serial Reaction Time Task (5CSRTT) 
An overlapping, but arguably separate form of attention is the ability to monitor in 
parallel a number of potential inputs, and allocate appropriate resources to each 
stimulus (Robbins, 1992; 2002). This type of divided attention is frequently assessed 
using dual-task performance paradigms in humans, whilst tasks such as the 5CSRTT 
may represent a suitably selective measure of spatial divided attention in the rodent.   
The 5CSRTT has been employed as the main assessment of divided spatial 
attention in rodents for three decades and has shown robust construct and predictive 
  
validity for modelling attentional and impulsive symptoms of human psychopathologies 
in the rodent (Young et al 2004; Hoyle et al, 2006; Siegel et al, 2011). The original, 
non-touchscreen version of the task has previously been discussed at length 
elsewhere (Robbins 2002; Chudasama and Robbins 2004; Young et al, 2009; Lustig 
et al, 2013). The 5CSRTT is also a component of the human CANTAB battery 
(http://www.cambridgecognition.com/academic/research). The 5CSRTT has been 
used widely for measuring divided spatial attention, and contrasts with the CPT which 
focuses on visual selective attention. In addition, the 5CSRTT allows for the specific 
measurement of premature and perseverative responding, and is as such better suited 
for the assessment of impulsivity and compulsivity as separate constructs. A separate 
human 4CSRTT has been developed explicitly to measure premature responding (e.g. 
in human drug abusers; Voon et al, 2014; Worbe et al, 2014). The rodent 5CSRT task 
has been successfully transferred to the touchscreen, and now offers measures of 
divided spatial attention, impulsivity and compulsivity within the same testing 
environment as the other tasks in the battery (thus allowing for cross-task 
comparisons when adopting a battery approach). 
The task is administered similarly to the standard operant chamber, with the 
exception that responses are made directly to the brief presentation of a white square 
(presented in one of 5 locations) on the touchscreen rather than by nose poking in 
response to a light flash (see Fig. 3). Response accuracy is taken as a measure of 
attentional ability, whilst perseveration and premature responding are considered 
indicative of compulsivity and impulsivity respectively.  A recent analysis (Mar et al, 
unpublished) shows that signal detection theory can also be employed to extract the 
relevant parameters of discriminability and response bias for this task. 
 The touchscreen 5CSRTT has been used widely with mice, and has proven 
sensitive to models of a range of disorders. When assessing genetic models of 
  
Alzheimer’s disease, Romberg et al (2011) found impaired accuracy, vigilance and 
perseveration of correct responses in the 3xTg mouse (Tau-P301L, APP-Swe and 
PS1-M146V), as well as impaired accuracy in the APP(695) model with Swedish and 
Indiana mutations (Romberg et al, 2013). The attentional impairment in 3xTg mouse 
could be rescued using the cholinesterase inhibitor Donepezil (Romberg et al, 2011) in 
a comparable manner to the rescue of attentional deficits of patients with Alzheimer’s 
disease following administration of the anticholinesterase drug 
tetrahydroaminoacridine (THA) measured using the CANTAB 5CSRTT (Sahakian et 
al, 1993). The touchscreen 5CSRTT is further sensitive to cholinergic manipulations 
as Bartko et al (2011) demonstrated using a global muscarinic (M1) acetylcholine 
receptor knock-out mouse. This model was not impaired on the task’s attentional 
measures (accuracy), but showed both compulsive and impulsive tendencies 
demonstrated as reduced omissions, and increased perseverative and premature 
responding. When reducing vesicular acetylcholine transporter (VAChT) in the 
prefrontal cortex specifically, a more subtle profile emerged in which VAChT deficient 
mice showed impaired acquisition, and increased omissions at short stimulus duration 
probes of high attentional demand (Kolisnyk et al, 2013b). When VAChT was 
overexpressed, mice displayed a profile of both impaired attention and impulsivity at 
shorter stimulus durations, with reduced accuracy and increased premature 
responding respectively (Kolisnyk et al, 2013). The task has also been used to assess 
a model of autism, the inbred BTBR T+tf/J mouse, which also showed reduced levels 
of prefrontal acetylcholine (McTighe et al, 2013). As in Kolisnyk et al (2013b), these 
mice showed impaired acquisition. In addition, an impulsivity phenotype was detected, 
as well as decreased accuracy at short stimulus durations.  
 With relevance to schizophrenia, Nithianantharajah et al (2013) assessed mice 
with mutations in Discs Large homolog (Dlg) family of synaptic scaffold proteins, which 
  
are implicated in the disorder. On the 5CSRTT, Dlg2-/- mice were impaired in 
acquisition and accuracy, and displayed reduced premature responding. In contrast, 
Dlg3-/+ mice showed increased accuracy and elevated premature responding 
compared to controls, indicating that these two genes have opposing regulatory 
functions. This highlights the ability of the task to detect both facilitation and 
impairment of performance.   
 In another demonstration of cross-species validation, the touchscreen 5CSRTT 
has recently been back-translated into a human touchscreen 4CSRTT (Worbe et al, 
2014). This task is designed specifically to measure premature responding. Following 
serotonin depletion (through dietary tryptophan depletion) in human volunteers 
premature responding increases, a highly similar pattern to that observed following 
serotonin depletion in rodents (Harrison et al, 1997a; Winstanley et al, 2004a). These 
data highlight the potential value of back-translation of tasks established in the pre-
clinical literature.  
 When used together, the rCPT and the 5CSRTT offer a comprehensive 
attentional assessment that covers both spatial divided attention, as well as selective 
and sustained visual attention. These have been used together in a battery approach 
in our research, and should be combined with an assessment of visual ability using a 
standard visual discrimination task (with care taken to avoid stimulus bias).  
 
Visual discrimination and reversal (2 or 3-stimulus versions) 
Measures of visual processing have been highlighted by CNTRICS (Green et al, 2009) 
in light of increasing awareness of impairments in patients with schizophrenia in this 
domain (Butler and Javitt, 2005). Visual discrimination measures associative learning 
and perceptual ability, and underpins successful performance in cognitive touchscreen 
tasks involving complex stimuli, including paired-associates learning (PAL), CPT and 
  
reversal learning. The visual discrimination task involves the simultaneous 
presentation of two visual stimuli. Responses to one stimulus are rewarded (S+) while 
responses to the second stimulus are non-rewarded (S-). The spatial location of the 
S+ is counterbalanced across trials. Over multiple trials, the rodent learns which 
stimulus is rewarded and develops a preference for selecting the S+ (see Fig. 4).  
 Visual discrimination in the touchscreen operant chambers offers good 
versatility relative to generally employed olfactory or spatial discrimination learning 
assays. Stimuli can be replaced across repeated discriminations to decrease proactive 
interference and repeatedly probe discrimination performance, for example in 
instances when varying degrees of perceptual difficulty of discriminations is desired. 
The set-up also allows for manipulations of perceptual load by altering stimulus size 
and stimulus contrast. Visual discrimination acquisition and performance is highly 
stable across laboratories, as is demonstrated by the multi-site study in the current 
issue (Talpos et al, this issue). Other more complex tasks can be built upon simple 
two-choice discrimination learning, including transverse patterning (Bussey et al, 
1998) and transitive inference (Silverman et al, 2013). Importantly, the acquisition of a 
visual discrimination allows for the assessment of cognitive flexibility through reversal 
learning, as once a standard visual discrimination has been acquired, the reward 
contingencies can be reversed to assess a central aspect of cognitive dysfunction in 
schizophrenia.   
 Reversal learning as measured in the reversal phases of the CANTAB ID/ED-
task of executive functioning is sensitive to deficits in patients with schizophrenia, 
independently of generalised intelligence (Leeson et al, 2009). These reversal learning 
deficits likely represent underlying abnormalities in fronto-striatal circuits, as these 
structures have been linked to reversal learning through imaging studies in humans 
(O’Doherty et al, 2003) as well as through excitotoxic and neurotransmitter-selective 
  
lesion studies in experimental animals (Bussey et al, 1997; Schoenbaum et al, 2002; 
McAlonan and Brown, 2003; Chudasama and Robbins, 2003; Kim and Ragozzino, 
2005; Bissonette et al, 2008; Ghods-Sharifi et al, 2008; Burke et al, 2009; Graybeal et 
al, 2011). Specifically, intact 5-HT signalling in the orbitofrontal cortex (OFC) and 
dopamine signalling in the caudate nucleus (primates) or dorsomedial striatum 
(rodents) is critical for successful reversal learning (Clarke et al, 2004; O’Neill and 
Brown 2007; Boulougouris et al, 2010; Clarke et al, 2011; Groman et al, 2013). The 
basolateral amygdala also plays an integral role in reversal learning (Stalnaker et al, 
2007; Izquierdo and Murray, 2007). However, less is known about the contribution of 
specific 5-HT and dopamine receptor subtypes, and there is demand for improved 
rodent reversal-learning paradigms that allow for the identification of novel drug 
targets outside of these neurotransmitter systems and the evaluation of putative 
cognitive enhancers in animal models of schizophrenia. Human and non-human 
primate assays of reversal learning commonly employ touchscreen methods to study 
visual reversal whereas rodent versions have often used alternative sensory 
modalities, such as the bowl-digging task (Birrell and Brown, 2000; McAlonan and 
Brown, 2003). Whilst this method is widely used and has provided important findings, 
it is more labour-intensive and more sensitive to experimenter interference than 
operant reversal learning assays. Importantly, tasks with vastly different testing 
apparatus lack the ability for cross-task comparisons, further emphasising the need for 
touchscreen-based reversal learning as part of a wider battery of touchscreen tasks.  
 The test battery presented in this review suggests two complementary reversal 
learning tasks for the assessment of visual reversal learning in the rat, namely the (2- 
or 3-stimulus) visual reversal task, and the visual serial reversal task. Generally, 
successful reversal learning requires the subject both to suppress prepotent 
responses at the now non-rewarded, previous S+ and to overcome the avoidance of 
  
the now rewarded, previous S-. These two processes might require separate forms of 
plasticity at the neural as well as behavioural levels; for instance, 5-HT depletion of the 
OFC in marmoset monkeys was linked to a lack of inhibition of a previously learnt 
response (Clarke et al, 2007), whereas the lesioned subjects performed at control 
levels when the previously correct stimulus was excluded. Another strategy, previously 
employed by Jentsch and colleagues (Jentsch et al, 2002; Lee et al, 2007) and now 
adapted to the touchscreen for rodents (Mar et al, 2012 poster; Alsiö et al, this issue), 
is to employ the simultaneous presentation of three visual stimuli (one S+, two S-). 
This paradigm gives the opportunity to analyse incorrect responses at a previously 
correct stimulus and responses at a never-reinforced stimulus (Fig. 5) and allows the 
dissociation of specific stimulus-perseveration (e.g., rats continues to respond at the 
‘previous S+’ but there is no increase in the number of errors at the ‘constant S-’ 
stimulus) from an overall impaired performance (increased number of errors both the 
‘previous S+’ and at the ‘constant S-’ stimulus). In addition, the difficulty of this 
paradigm (3-stimulus instead of 2-stimulus discrimination learning) increases the 
dynamic range within which to detect performance improvements.  
 
2-stimulus visual serial reversal learning  
The second reversal learning task included in the test battery is the visual serial 
reversal learning task. Whereas most rodent operant discrimination and reversal 
assays – including touchscreen tasks - require multiple sessions to reach the criterion 
for successful reversal learning (a single reversal can extend >14 days and therefore 
requires extended periods of daily testing; Mar et al, 2013), the visual serial reversal 
task offers an alternative wherein reversal learning data can be obtained within 3 
sessions. The difference in training time to reversal criterion may be acceptable for 
chronic manipulations (e.g., genetic modifications or excitotoxic lesions) and/or 
  
systemic treatment (e.g., serotonergic manipulations; Boulougouris et al, 2008), but 
the tasks have less utility for neuropsychopharmacological investigations due to the 
high number of required intracerebral microinfusions. Moreover, whereas there are 
large differences between individuals in their visual reversal performance (regardless 
of testing apparatus), performance does not vary much across reversals within each 
subject in either non-human primates (Groman et al, 2013) or in rats (Barlow et al, in 
press). The problem of between-subject variability in performance can be avoided by 
focusing on within-subject manipulations across reversals to increase statistical power. 
To exploit this, the serial visual reversal task requires each rat to complete a number 
of reversals, allowing for measures of stable performance across serial reversals 
(Alsiö et al, this issue). The task is optimised to produce significant perseveration 
behaviour after each contingency shift; that is, each reversal allows for measures of 
perseveration as you would obtain in a single reversal design. This highly versatile 
task was validated by pharmacological inactivation of the OFC (Alsiö et al, this issue) 
and will allow further investigation of the neural circuitry and 
neuropsychopharmacology of visual reversal learning in rats (Fig 6). 
 
Self-Ordered Working Memory (rSOWM) task 
A central cognitive domain impaired in patients with schizophrenia is working memory 
(Piskulic et al, 2007). This refers to the ability to maintain and utilise information 
appropriately over a short time period, without allowing irrelevant information to 
interfere with this process (Barch et al, 2009). Working memory deficits in patients with 
schizophrenia do not appear to be modality specific, as they are detected using 
auditory and visuospatial stimuli (Forbes et al, 2009). Impaired working memory is 
observed in first-degree relatives of patients (Park et al, 1995), suggesting that there is 
a genetic contribution to the phenotype of spatial working memory deficits regardless 
  
of whether the potential genetic vulnerability to schizophrenia the first-degree relatives 
of patients may be carriers of is expressed or not.  
 The CNTRICS recommendations for tasks measuring working memory deficits 
in patients with schizophrenia are the AX-Continuous Performance Task/Dot Pattern 
Expectancy task and the recent probes and operation/symmetry span task (Barch et 
al, 2009). Whilst these tasks are highly valuable in a clinical setting, there are 
challenges associated with developing rodent analogues due to the complex nature of 
the task designs and the types of stimuli used (e.g. maintaining a span of read words 
or mathematical operations). Furthermore, the AX-CPT task may be sensitive to 
patient impairments partly because of the combined load on both attention and 
working memory. In contrast, the battery approach adopted in the current review aims 
to dissect cognitive function accurately, and for this tasks should load predominantly 
on a single construct of interest. We therefore chose to attempt to isolate working 
memory by focusing on the touchscreen CANTAB spatial working memory (SWM) 
task, which utilises nonmatching-to-sample rules and a number of distinct, illuminated 
screen locations, two features commonly used in pre-clinical behavioural tasks such 
as the Trial-Unique Non-matching to Location (TUNL) task, which was highlighted by 
the Selecting Promising Animal Paradigms meeting of CNTRICS focused on working 
memory (Dudchenko et al, 2013). The novel rSOWM test has the added strengths of 
requiring a series of self-generated choices (in which strategic responding can aid 
performance and is sensitive to prefrontal disruption) across a variable number of 
choice options (an important parameter taxing working memory load), more akin to 
human SWM paradigms. Importantly, the CANTAB SWM task has repeatedly detected 
spatial working memory impairments in patients with schizophrenia (Pantelis et al, 
1997; Elliott et al, 1998; Joyce et al, 2002; Hutton et al, 2004; Badcock et al, 2005; 
Joyce et al, 2005), including ‘at-risk’ patients (Wood et al, 2003). Moreover, this task is 
  
also sensitive to the performance-enhancing effects of modafinil both in healthy 
volunteers (Muller et al, 2013) and in first episode patients with schizophrenia 
(Scoriels et al, 2012). The CANTAB SWM requires subjects to collect tokens hidden 
beneath boxes on a touch sensitive screen. The number of boxes varies based on 
determined task difficulty and the subject is free to search the boxes in any order. 
Once a token is found, the next token is available at a different location. A box is never 
baited with a token more than once, requiring subjects to remember boxes that have 
been visited (non-match rule).    
 The rodent self ordered working memory task (rSOWM; Mar et al, unpublished; 
Mar et al, 2012 poster; Gamallo-Lana et al, 2014 poster) aims to provide a rodent 
analogue of the CANTAB spatial working memory (SWM) task. The basic paradigm 
measures the capacity to monitor and correctly remember self-generated choices of 
stimuli presented on a touchscreen. In this task, rats are presented with a series of 
trials in which either 2, 3 or more “white square” stimuli are displayed at different 
positions on the monitor (Fig 7). Within each trial, rats are rewarded each time they 
select a stimulus they have not previously selected. If a mistake is made, the animal 
must select again until a novel location is touched. Each trial ends when all stimuli 
have been selected once. Task performance is typically assessed using the 
percentage of perfect trials (in which each stimulus option was selected only once) 
and/or the number of errors (revisits to previously-selected stimuli). Response 
latencies can be examined as well as possible behavioural strategies based on the 
order/sequence in which stimuli are chosen within trials. 
 There are a variety of parameters that can be manipulated in the rSOWM. The 
delay between the opportunities for choice within trials can be lengthened to tax 
working memory, requiring the animal to maintain information about their previous 
choice “on-line” for a longer period of time. The interval between trials can be 
  
manipulated to vary the amount of trial-to-trial interference. The physical distance 
between stimuli can be varied as a measure suggested to tax spatial pattern 
separation, a dentate gyrus (DG)-dependent process by which similar inputs are made 
more distinct to facilitate successful storage and retrieval of a representation (e.g. 
Leutgeb et al, 2007). Relevant molecular and cellular changes have been observed in 
patients with schizophrenia, suggesting that DG dysfunction may be of particular 
interest (Gao et al, 2000; Knable et al, 2004). Indeed, these changes appear to lead to 
behavioural dysfunction manifested as reduced pattern separation ability in patients 
with schizophrenia compared to healthy controls (Das et al, 2014). The number of 
stimuli can also be manipulated to increase memory load as in the CANTAB SWM 
task. By including trials having 3 or more locations/stimuli and by intermixing the 
number of stimuli and their positions between trials, the use of potentially confounding 
simple alternation strategies commonly observed in other working memory procedures 
(e.g., DNMTS) is largely prevented in the rSOWM. Additionally, potential sequencing 
strategies used by the animal can be probed by forcing the initial choice(s) on a given 
trial (e.g., present only one stimulus option to start a given trial – similar to the TUNL 
and cTUNL procedures described below). 
 This task has been demonstrated to be sensitive to the differential and 
detrimental effects of fibre-sparing neurotoxic lesions of specific hippocampal 
subregions (Mar et al, unpublished): DG lesioned rats show pronounced general 
impairments in task performance whereas CA3-lesioned animals are impaired when 
switched to sessions where delays precede stimulus presentation within trials. These 
effects mirror published reports implicating both the DG and the CA3 in working 
memory performance (Walsh et al, 1986; McLamb et al, 1988; Emerich and Walsh, 
1989; Gilbert and Kesner, 2006). The task has also been demonstrated to be sensitive 
to the cognitive enhancing effects of low-moderate doses of modafinil (Mar et al, 
  
unpublished; Gamallo-Lana et al, 2014 poster). Healthy adult male rats showed dose-
dependent improvements in the percentage of perfect trials following systemic as well 
as intra-mPFC modafinil administration. These improvements were observed 
selectively on higher load, 3-stimulus trials (not on 2-stimulus trials), mirroring the 
recent results using the human CANTAB SWM test in healthy volunteers in which the 
cognitive enhancing effects of modafinil were only observed under higher load 
conditions (Muller et al, 2013). 
 
Continuous Trial-Unique Non-matching to Location (cTUNL) and TUNL tasks 
The prevalent automated spatial working memory in rodents has been an operant 
delayed-non-matching-to-position (DNMTP) task. This paradigm differs from the 
CANTAB SWM task in that the animal is required to remember a single location (left or 
right) across a delay and respond to one of two presented levers. The validity of 
automated DNMTP tasks has been questioned due to presence of mediating 
behaviours reducing the need to maintain information on line during the delay 
(Chudasama and Muir, 1997). In response to this criticism, we have developed novel 
variants of the previously published and validated Trial-Unique Non-matching to 
Location task (TUNL; Talpos et al, 2010; McAllister et al, 2013), which was been 
described in detail elsewhere (Oomen et al, 2013). Here we focus on the new 
NEWMEDS development of continuous TUNL for the rat (cTUNL; Oomen et al, this 
issue, Hvoslef-Eide et al, this issue, Howe et al, this issue) and a mouse version of the 
TUNL task (Kim et al, this issue). These tasks differ from the SOWM task in that there 
is no opportunity for self-selection of the order of responses.   
 In all the variants of this task, one can parametrically vary both the delay 
between sample and choice, and the physical distance between the stimuli on the 
screen. The TUNL task has a standard Sample and Test phase, whereby one of 15 
  
possible locations on the screen is illuminated with a white square at Sample. 
Touching the sample results in reward on 1/3rd of trials to maintain motivation to 
respond. After a delay, the same location is re-illuminated, along with a novel location 
at Test. The animal is required to non-match to location by selecting the novel location 
(S+). Given the number of locations on the screen, the ability of the rat to predict which 
of the remaining 14 locations will be illuminated as novel is greatly reduced, and 
indeed, detailed behavioural analysis of TUNL performance indicated minimal 
advantage from use of mediating strategies (Talpos et al, 2010).  
 cTUNL differs from TUNL in a number of ways. Firstly, the trial structure is 
continuous in nature, so that the S+ location on the previous trial becomes the S- 
location on the current trial (Fig 8). This results in all trials being choice trials (i.e. data 
are collected from every trial, as opposed to 50% of touches as in TUNL). This 
structure has the advantage of halving the time it takes for the animal to acquire the 
task, a practical, but important concern. Secondly, (and more theoretically important), 
the continuous nature of the task allows one to vary the similarity (separation) of 
locations at both the encoding and retrieval stages of the task. In other words, 
because there are always two stimuli on the screen, the successful encoding of a 
location as unique on the previous trial depends on the proximity of that location to the 
other (“encoding phase”), and the ability to avoid that location on the current trial 
depends on the proximity of the S- to the novel S+ (“retrieval phase”). This is important 
because pattern separation is hypothesised to be a process active at the encoding 
stage (i.e. representations are made more unique to allow for successful storage and 
retrieval, rather than retrieved as two overlapping representations that are then made 
more unique to allow for accurate use of a single representation). The effects of 
manipulations that affect pattern separation (e.g. knock-down of adult neurogenesis; 
e.g. Clelland et al, 2009; Nakashiba et al, 2012) are therefore hypothesised to have a 
  
greater effect at encoding than retrieval in such a task (Bekinschtein et al, 2013), 
which can now be measured using cTUNL. The cTUNL task has been validated as 
sensitive to dysfunction of the dentate gyrus subregion of the hippocampus, but 
interestingly leaves performance unaffected when the CA3 region is targeted (Oomen 
et al, this issue). The task has also been used with disease models of schizophrenia, 
demonstrating impaired acquisition and performance of MAM-E17 rats (Howe et al, 
this issue), mirroring reports of deficits in MAM-E17 on hand run hippocampus-
dependent tasks, such as the Morris water maze, the T-maze and the Y-maze 
(Gastambide et al, 2015). 
 A final task feature of cTUNL is the ability to increase the number of stimuli on 
the screen to manipulate the amount of proactive interference in the task, as was 
originally implemented in the rSOWM (Mar et al, unpublished) to resemble the human 
CANTAB SWM task. For example, if the 3-stimulus version of the task is used, the two 
most recently touched (but both S-) locations will be presented on the screen 
alongside a novel location (S+), rather than a single S- as in the 2-stimulus version 
(Fig. X). In this issue, we demonstrate that both the 2- and 3-stimulus version of 
cTUNL is impaired following permanent inactivation of the DG (Oomen et al, this 
issue). Furthermore, the task has been validated as dependent on prefrontal function 
in a delay-dependent manner, as temporary inactivation of the medial prefrontal cortex 
(mPFC) in rats impairs performance at long, but not short delays (Hvoslef-Eide et al, 
this issue). The task can also detect facilitations in performance of young, healthy rats 
following infusions of phenylephrine into mPFC, an important task attribute for 
preclinical drug discovery.  
 At this time, it is clear that both rSOWM and cTUNL are sensitive to DG 
dysfunction, whilst TUNL is sensitive to full lesions of the hippocampus. In terms of 
medial prefrontal cortex contributions, cTUNL performance is modulated by adrenergic 
  
and GABAergic agonists infused into PFC, whilst rSOWM is sensitive to both 
microinfusions and systemic delivery of modafinil into PFC. However, as validation 
work is a continuous process, these tasks may emerge as dissociable based on other 
neurocognitive and neuropharmacological manipulations. Certainly, they differ in 
practical aspects which may be relevant when selecting a touchscreen task for spatial 
working memory. For example, the rSOWM task has high face validity when compared 
to the CANTAB spatial working memory task, as they both allow the rodent/participant 
to select the order of responses to stimuli. In addition, stimulus load and the inter-trial 
interval (lTI) can be independently manipulated. However, if one is searching for a 
spatial working memory task not influenced by the element of self-selection of stimuli, 
TUNL or cTUNL offers alternatives, with the possibility of manipulating stimulus load in 
cTUNL, and the ITI independently from delay in TUNL.  
 
Mouse TUNL 
The assessment of spatial working memory in mice has relied heavily upon maze-
based tasks, although lever-based operant chamber methods for the assessment of 
this construct are available (e.g. Estapé and Steckler, 2001). It has been argued that 
the acquisition of lever-pressing behaviour in mice is slower to establish than nose-
poke based operant behaviour due to a murine preference for holes compared to 
levers (Crawley, 2000; Baron and Meltzer, 2001). We have developed a mouse 
version of the published rat touchscreen TUNL task (Talpos et al, 2010) that allows for 
the manipulation of both separation between the sample and test location, as well as 
the delay between sample and test choice. This may have advantages in terms of the 
readiness of mice to nose-poke touchscreens in response to visual stimuli, as well as 
enabling the assessment of spatial working memory in the mouse within a 
touchscreen battery (enabling cross-task comparisons of performance). The mouse 
  
TUNL task uses a simplified grid of 5 locations (Fig. 9) and a somewhat different 
training approach compared to the rat outlined in detail in Kim et al (this issue). 
Despite the reduced number of grid locations, no mediation behaviours were 
observed, and mice were encouraged to engage with the magazine during the delay 
(thus avoiding body positioning as a strategy) using intermittent rewards. Control 
mouse performance is delay dependent, and the task is sensitive to dorsal 
hippocampal lesions (Kim et al, this issue).   
 
Paired-associate learning (PAL) 
Long-term memory impairments in patients with schizophrenia manifest as deficits in 
declarative memory, indicating the prefrontal cortex and the hippocampus as central 
structures of dysfunction (Aleman et al, 1999; Simons and Spiers, 2003). Tasks based 
on forming associations between stimuli (such as object and place) rely upon 
concurrent activity between these regions (Eichenbaum, 1999, 2000; Milner et al, 
1997; Owen et al, 1995; Simons and Spiers, 2003). The CANTAB object-location 
paired-associate learning (PAL) task is highly sensitive to impairments in patients with 
schizophrenia (Barnett et al, 2005; Chouniard et al, 2007; Donohoe et al, 2008, Aubin 
et al, 2009) and performance correlates with symptom severity (Prouteau et al, 2004, 
2005; Ritsner and Blumenkrantz, 2007). The task is also sufficiently sensitive to detect 
patients with schizophrenia from individuals with schizo-affective disorder (Stip et al, 
2005).  
 The rodent touchscreen PAL task is available for both rats and mice (Talpos et 
al, 2009; Horner et al, 2013; Bartko et al, 2011), and assesses memory for 
associations between visual stimuli (A, B, C) and specific locations on the screen (1, 2, 
3; see Fig 10), although see Kim et al (this issue) for an alternative version of PAL for 
  
mice. The task was recommended by CNTRICS for the assessment of long term 
memory in rodents (Bussey et al, 2013).  
 On every trial, two patterns are presented; one pattern is in its correct position 
(e.g. A in 1, S+), whilst the other pattern is in one of its two incorrect positions (e.g. B 
in 3, S-). The third location is left blank, and is illustrated by an empty, white frame. 
Touchscreen rodent PAL requires activation of AMPA and NMDA receptors in dorsal 
hippocampus to maintain performance (Talpos et al, 2009), whilst an intact prefrontal 
cortex is necessary for control-level acquisition of the task (Bussey et al, this issue). 
The current version of the task (Horner et al, 2013) utilises luminance matched 
patterned stimuli as displayed in Fig. 10, as this results in a more homogenous 
acquisition curve of the 3 object-location associations (Hvoslef-Eide et al, 
unpublished). Traf2 and NcK interacting kinase (TNiK), linked to both NMDA and 
AMPA receptor function, also impairs acquisition of PAL when knocked out in mice 
(Coba et al, 2012), whilst adult neurogenesis in the dentate gyrus has no effect on 
PAL acquisition (Clelland et al, 2009). Performance appears linked to the cholinergic 
system, as scopolamine and dicyclomine cause impairments in mice (although note 
that effects in rats may differ), whilst Donepezil facilitates performance (Bartko et al, 
2011b). Furthermore, PAL performance is impaired by phencyclidine (PCP) and 
amphetamine when administered systemically (Talpos et al, 2014).  
 In a cross-species study, Nithianantharajah et al (2013) assessed mice and 
human carriers of the Dlg2 mutation, which is implicated in schizophrenia. The Dlg2 
mice were impaired on the rodent PAL task, whilst humans carrying the Dlg2 mutation 
were impaired on CANTAB PAL. In more recent (as yet unpublished) work, the same 
human participants were assessed on the rodent PAL task with no modifications, and 
found to display the same phenotype as the mouse model. This important 
demonstration of successful translation from rodent to human is one that will be 
  
pursued further using other tasks in the battery as validation work continues beyond 
the specific boundaries of the NEWMEDS project.  
 
Challenges and limitations 
It is evident that the touchscreen method has many advantages. However as with any 
method there can be limitations. For example, certain rodents may present with visual 
impairments that may preclude the use of at least some of the tasks in the battery. 
One of the challenges of the NEWMEDS project has been the development of 
touchscreen operant chamber tasks for rodents that fulfil the requirements of both 
academia and the pharmaceutical industry, whereby the task “wish lists” do not 
necessarily perfectly overlap. For example, the speed of acquisition of a particular 
task, as well as the stability of a performance baseline for repeated drug testing can 
be desirable task criteria for drug development, and some tasks meet these criteria 
more readily than others (e.g. cTUNL and rCPT, as compared to PAL). Although the 
NEWMEDS project has formally completed, the communication between the industrial 
and academic partners will continue, and in parallel, continued efforts to further 
optimise both the implementation and further development of the task battery for drug 
discovery. 
 
Future directions 
Whilst the rodent touchscreen battery presented here focuses on cognitive domains, 
there are a range of additional psychological constructs that could be assessed in the 
touchscreen operant chamber to form a wider battery for schizophrenia-relevant 
behaviour, such as motivation, attentional set-shifting and perceptual processing.  
 
  
Motivation and reinforcement learning was highlighted by a CNTRICS working group 
(Markou et al, 2013) as a reflection of extensive evidence of impairments in patients 
with schizophrenia (e.g. Gard et al, 2007; Gold et al, 2008; Weiler et al, 2009; Barch 
and Dowd, 2010; Kasanova et al, 2011; Dowd and Barch, 2012; Yilmaz et al, 2012; 
Gold et al, 2013; Barch et al, 2014; Gard et al, 2014; Griffiths et al, 2014). Some of the 
tasks proposed by the working group are already established in the touchscreen, such 
as autoshaping, which has been successfully used in both rat and mouse models 
(Bussey et al, 1997b; Parkinson et al, 2000, 2000b; Dalley et al, 2005; Ito et al, 2005; 
DePoy et al, 2013; Horner et al, 2013). Others, such as progressive ratio (Heath et al, 
this issue), probabilistic (selection) learning task (rPST; Mar et al, unpublished; 
Trecker et al, 2012 poster; Markou et al, 2013) and notionally a version of an operant 
probabilistic reversal paradigm that can assess bias to negative and positive feedback 
(Bari et al, 2010) are the focus of current development and validation, and will together 
form a battery to screen for motivational and reinforcement learning-related deficits to 
complement the current range of preclinical touchscreen tasks.  
Furthermore, we and others have made strides towards a rodent intra- and 
extra-dimensional set shifting task in the touchscreen using two visual dimensions 
(Brigman et al, 2005; Dickson et al, 2014), a valuable contribution for cross-species 
comparisons with both monkey (e.g. Roberts et al, 1988) and human literature (e.g. 
Downes et al, 1989; Owen et al, 1993) including schizophrenia, (Pantelis et al, 1999; 
Barnett et al, 2010).  
Another future avenue for development is the assessment of complex visual 
perceptual processes in the rodent. This would be of significant value, given the 
occurrence of alterations in visual perception in schizophrenia such as deficient 
perceptual organisation (Giersch and Rhein, 2008; Giersch et al, 2011; Silverstein and 
Keane, 2011). Despite frequent reports of poor visual ability in these species (e.g. 
  
Kumar et al, 2015), work from our laboratory has previously shown that even rats of 
the non-pigmented Sprague-Dawley strain are proficient at successfully discriminating 
between two complex visual stimuli presented on the touchscreen (Bussey et al, 
2008). Furthermore, accumulating evidence suggests that rodents likely possess the 
computational capacity necessary for higher-order visual processing thought unique to 
primates (Huberman and Niell, 2011; Niell, 2011; Zoccolan, 2015). The touchscreen 
approach can therefore be readily leveraged to examine higher-order visual 
processing and perceptual mechanisms in rodents for which the number of available 
experimental manipulations is considerably greater than in the cat or primate 
conventionally used in vision research. This is exemplified by the recent development 
of a rat touchscreen paradigm (Ward et al, 2013) to assess perceptual organisation 
through evaluation of contour integration (Feigenson et al, 2014). Performance in this 
paradigm is sensitive to acute administration of the NMDA receptor antagonists PCP 
and ketamine (Ward et al, 2013) suggesting that it may be of use in mechanistically 
assessing changes in visual perception associated with a psychosis-like state. The 
present CPT task is also in fact sensitive to selective perceptual deficits caused by 
PCP treatment based on its contrast sensitivity component (Mar et al, 2013 poster). 
 
Summary 
The rodent touchscreen cognitive test battery presented represents the NEWMEDS 
WP02 consortium’s contribution to pre-clinical schizophrenia research, focused heavily 
on improving the interlinked concepts of construct and predictive validity. Following on 
from the efforts of MATRIC and CNTRICS, our goal has been to develop a set of tasks 
that tap into cognitive constructs highly relevant to schizophrenia that are in a position 
to predict compound success in a clinical population, in addition to evaluating models 
of disease. The model of academic task development and validation followed by 
  
further validation and utilisation by pharmaceutical partners will continue to come to 
fruit following the end of this project. One important validation effort will be 
demonstrations of back-translational studies reproducing specific cognitive 
impairments found in patients with schizophrenia in animal models, as well as effects 
of cognitive enhancing compounds. Whilst highly valuable as positive controls, such 
effective compounds are challenging to identify in humans. Nevertheless, modafinil 
could serve as a good candidate for back translational studies, as it has been effective 
in enhancing cognition in both healthy volunteers (Winder-Rhodes et al, 2010; Muller 
et al, 2013) and patients with schizophrenia (Turner et al, 2004). With this approach in 
mind, we hope that the developed battery will aid in bridging the gap between rodent 
and human cognitive testing, with the ultimate goal of aiding drug discovery for novel 
treatments of schizophrenia.  
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Fig. 1 An overview of the NEWMEDS initiative. The current review focuses on work 
carried out within work package 2 (WP02). 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 A schematic of the rodent continuous performance test. One stimulus is 
assigned as the target (S+), and four stimuli are assigned as non-targets (S-). As 
  
demonstrated in the exemplar presentation sequence on the left hand side, an empty 
white (unresponsive) square is present during the ITI. A response to the presence of 
the target is recorded as a hit. Responses to a non-target stimulus are recorded as a 
false alarm. A false alarm will result in the next stimulus being a non-target stimulus 
(correction trial; see exemplar presentation sequence on the right hand side). Touches 
to the empty white square resets the ITI. Inhibition of responding to a non-target is 
recorded as a correct rejection. Inhibition of responding to a target is recorded as a 
target omission (not shown). Central stimuli can be flanked by congruent or 
incongruent stimuli during distractor probes (see top right; incongruent example 
shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 A schematic example of four trials in the rodent touchscreen 5-choice serial 
reaction time task.  In each trial, a white-square stimulus is presented in one of five 
horizontal response windows following a delay. A nosepoke response to the white-
  
square stimulus is scored as a correct response. A response to a blank response 
window during the presentation of the stimulus is treated as incorrect response. 
Response to the screen before the onset of the white square stimulus is treated as a 
premature response. Responses to the screen after the offset of the stimulus are 
treated as a perseverative response (to either correct or incorrect locations). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Fig. 4 A schematic of the rodent 2-stimulus visual discrimination and reversal task with 
representational 2-stimulus reversal learning performance. A) During visual 
discrimination acquisition, responses to one stimulus (S+) are rewarded while 
responses to the second stimulus (S-) are not. The spatial locations of stimuli are 
counterbalanced across trials, but reward contingencies remain unchanged. Following 
successful acquisition of a visual discrimination, the reward contingencies are 
reversed, resulting in the previous S- becoming the S+. B) In the initial stages, 
performance is below chance (50%) driven by a preference for the previously 
rewarded stimulus. After repeated exposure to the new reward contingencies, 
preference shifts to the now rewarded stimulus. 
a 
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Fig. 5 A schematic of the rodent 3-stimulus visual discrimination and reversal learning 
task with representational 3-stimulus reversal learning acquisition curve. A) During 
visual discrimination acquisition, responses to one stimulus are rewarded while 
responses to the two other stimuli are non-rewarded. In the subsequent reversal 
sessions, responses to one of the previously non-rewarded stimulus become 
rewarded while responses to the previously rewarded stimulus become non-rewarded. 
Responses to the third stimulus remain non-rewarded in both discrimination and 
reversal learning. B) Data illustrating responses to the three stimuli over 10 reversal 
sessions in the rat. The responses to the constantly S- stimulus remain low 
throughout. The responses to the previous S+ are initially high, before gradually 
a 
b 
  
reaching comparable levels to the constantly S- stimulus. The responses to the 
previously S- are initially high, before gradually becoming the preferred stimulus.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 A schematic of the rodent serial visual reversal learning task with 
representational 3-stimulus reversal learning acquisition curve. A) During visual 
discrimination acquisition, responses to one stimulus are rewarded while responses to 
the two other stimuli are non-rewarded. In the subsequent reversal sessions, 
responses to one of the previously non-rewarded stimulus become rewarded while 
responses to the previously rewarded stimulus become non-rewarded. Repeated 
reversals of the reward contingencies using the same stimuli results in a shortening of 
the number of sessions rats require to successfully reverse. B) Data illustrating 
responses two reversals of reward contingencies within 10 testing sessions in the rat. 
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Fig. 7 A schematic of a perfect trial in the rodent self ordered working memory task. A) 
At the first choice, responses to any of the stimuli on the screen results in reward (all 
S+). After a delay, all stimuli are presented again. The previously touched stimulus is 
now a S-, and the animal must respond to either of the remaining stimuli for reward. 
After a delay, the two previously touched stimuli are now S-, and the animal must 
respond to the remaining stimulus for reward. A revisit to a previously touched 
stimulus results in an error, and all stimuli are presented again. This will continue until 
all stimuli have been touched once. B and C) The separation between stimuli on the 
screen can be manipulated on both the 2-stimulus (b) and 3-stimulus (c) trials.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 A schematic of a four trials of the 2-stimulus and 3-stimulus version of the 
continuous trial-unique non-match to sample task. On trial 1, a single sample location 
is illuminated (S+). After a delay, the same location is presented again (S-), along with 
a novel location (S+). The separation between the two stimuli can be varied 
(presented is a separation 0 trial, in which no squares separate the S+ and the S-). In 
the 2-stimulus version of the task, the trials continue to display only two stimuli at a 
time, with the previously correct location always serving as the S-. In the 3-stimulus 
version of the task, the two previous S+ locations are presented (now both S-) 
alongside a novel location (S+). From the third trial onwards, every trial contains a 
choice of three locations, with the two previously correct locations always serving as 
the S-. Correction trials are utilised throughout the task, so that a response to a S- 
results in the re-presentation of the same spatial configuration on the screen until a 
correct response is made.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 A schematic of two trials of the mouse trial-unique non-match to sample task. A 
trial begins with a sample-phase where a white-square stimulus (occasionally 
rewarded to maintain responding) is presented in one out of five possible horizontally 
oriented response windows. Upon touch, a delay is implemented. After the delay, the 
sample location (now S-) and a novel location (S+) is presented. If a response to the 
sample location (S-) is made, a correction trial is implemented whereby the same two 
locations are presented again until a correct response (S+) is made. Following a 
correct response, an ITI is initiated. After the ITI, a second trial (sample and test 
phase) is initiated. The spatial separation between stimuli and the delay between 
sample and choice can be manipulated as in rat TUNL, cTUNL and SOWM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10 A schematic of four trials of the paired-associate learning task. Across each 
trial the PAL task, two out of three possible stimuli appear on the screen in two out of 
three possible locations (giving six possible trial combinations). One stimulus is 
displayed in its correct location (S+) while the second stimulus is displayed in one of 
its two incorrect locations (S-). The third location is left blank. Responses to the S+ are 
rewarded while responses to the S- are not. In this example, the diagonal lines are 
correct (S+) when presented in the left-most response location, the horizontal lines are 
correct (S+) when presented in the central response location, and the vertical lines are 
correct (S+) when presented in the right-most response location. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1 An overview of the MATRICS and CNTRICS domains highlighted as relevant to 
schizophrenia (Marder and Fenton, 2004; Carter and Barch, 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2 An overview of the rodent touchscreen tasks included in the battery for 
measuring cognitive function relevant to schizophrenia. Several MATRICS and 
CNTRICS defined cognitive constructs support performance on individual tasks (M = 
MATRICS, C = CNTRICS; see Table 1 for a numbered overview of domains). 
Constructs in brackets are not the primary construct for which this task would be 
recommended to test, but nevertheless supports general performance or acquisition of 
the task. M3 is highlighted with a question mark due to the challenges of applying this 
construct to animal cognition.  
 
 
 
